Patiromer sorbitex calcium由Relypsa公司研制开发,商品名为Veltassa。该药是一种非吸收的钾结合剂,于2015年10月21日批准上市,适用于高血压及高血钾症的治疗,但不适用于严重高血钾症的紧急治疗~([1])。Patiromer sorbitex calcium的中文化学名称:载山梨糖 Patiromer sorbitex calcium developed by Relypsa company under the trade name Veltassa. It is a nonabsorbed potassium-binding agent approved for marketing on October 21, 2015 and is suitable for the treatment of hypertension and hyperkalemia but not for the treatment of severe hyperkalemia. ]). Chinese chemical name of Patiromer sorbitex calcium: sorbose